Evaluation of Clinical and Antibody Response to Covid-19 Vaccination Strategy in TBRI, Egypt
Covid19
About this trial
This is an interventional screening trial for Covid19
Eligibility Criteria
Inclusion Criteria:
- All male and female above 18 years
Exclusion Criteria:
- age below 18 years -pregnancy-
- fever
- IGM positive for covid 19
Sites / Locations
- Samia El-ShishtawyRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Other
Other
Other
Other
Other
1- Before vaccination:
2-7 days after the first dose
3-Before the second dose:
4-After 3 months from the second dose:
5-After 6 months from the second dose:
To detect: COVID-19 IgG/IgM Rapid Test COVID-19 IgG/IgM by quantitative method(ELISA). D-dimer
Measuring D-dimer
To detect IgG and IgM To detect the level of Covid-19 Ig G antibodies titer in the blood, Quantitative Ig G titer should be measured. To detect the response of the immune system to the vaccine.
To detect the level ofCovid-19 Ig G antibodies titer in the blood, Quantitative Ig G titer should be measured. To detect the response of the immune system to the vaccine.
To detect the level ofCovid 19 Ig G antibodies titer in the blood, Quantitative Ig G titer should be measured. To detect the response of the immune system to the vaccine.